Business
ASX to drop from seven-month high, Wall Street slips on COVID-19 vaccine delay – ABC News
Australian shares are expected to drop in early trade, after hitting a seven-month high on Tuesday, as Johnson & Johnson delays its vaccine trial.
Australian shares are expected to drop in early trade, after hitting a seven-month high on Tuesday.
Key points:
- The ASX 200 has jumped 6.5pc since October 1
- The Australian dollar has risen 3.1pc in the past three months
- Markets fell after Johnson & Johnson and Eli Lilly delayed their COVID trials
ASX futures were down 55 points (or 0.9 per cent) by 7:10am AEST.
The Australian dollar had also fallen (-0.7pc) to 71.58 US cents, on reports that China has st…
Continue Reading
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts